Latest Zymeworks News & Updates

See the latest news and media coverage for Zymeworks. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Zymeworks

Global biotechnology company developing medicines and managing licensed assets

zymeworks.com
Headquarters
Vancouver, Canada
Founded year
2003
Company type
Public company
Number of employees
260–500

Last updated

Latest news about Zymeworks

In short: Zymeworks authorized a $200 million buyback, raised guidance, completed its Theravance acquisition and advanced a Roche partnership.

Company announcements

Zymeworks

Zymeworks closes Theravance merger and raises $350M

Theravance becomes a subsidiary while CVRs are issued to shareholders. Senior secured notes with an 8.25% interest rate mature in 2036.

Unlock all announcements with a

Media coverage

The Globe and Mail

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition - The Globe and Mail

Acquisition diversifies durable cash flows and advances Zymeworks' strategy to build a productive R&D company with a growing portfolio of revenue-generating assets YUPELRI ® expected...

Unlock all articles with a

Never miss news about Zymeworks

Track Zymeworks and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.